Again, contrasting results for SOX2’s role in the clinic were highlighted in lung cancer (including NSCLC and SCLC), where SOX2 was correlated to improved survival and better patient outcome [62,67,68,86-88]. The gene discussed is SOX2; the disease is small cell lung carcinoma.